in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Phage Pharmaceuticals, the USP and Nycomed.
Algeta has signed a deal making it the exclusive supplier of Alpharadin (radium-223) to Bayer, prompting the expansion of the production facility at IFE.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, ACR Image Metrix and Health Decisions.
While the summer* heat may slow other industries, the outsourcing sector keeps on moving. Oustourcing-pharma rounds up the key developments, featuring LyoTechnica and AspenTech
Indian contractor Terrene Pharma has filed a DMF for hard gelatin capsules with the US FDA, signalling its intention to expand in the world’s most lucrative drug market.
Mandatory recalls of drugs posing an imminent threat to human health could be initiated by the US FDA if a bill introduced last week is passed into law.
Preclinical CRO Lab Research says new contracts are a sign of continuing recovery in market as well as firm’s ability to attract broader clientele base.
A group of Irish drug firms and banks plan to set up a “global pharmaceutical centre of excellence” (COE) that they believe will create 4,800 research, development and manufacturing jobs.
Encorium has bought Progenitor International Research, furthering efforts to fix its financial woes by focusing on vaccines, oncology and growth in emerging markets.
Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.
GSK and Pfizer’s ViiV Healthcare JV says it will make its entire drug portfolio available to generics manufacturers and 80 per cent the global HIV-infected population.
Penn Pharma and Xcelience have formed an Xcelodose-focused joint venture to meet client demand in Europe and Asia for powder-in-capsule (PIC) services.
Major Charles River Laboratories (CRL) shareholder Jana Partners says Wuxi PharmaTech deal would generate inadequate returns, citing “industry” concerns about integration.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new leader at PhRMA and KV replacing its CFO after three months in the job.
Mylan are to acquire Bioniche Pharma’s global injectable pharmaceuticals business for $550m (€430m) in a deal that gives Mylan a significant foothold in meeting product and therapeutic gaps in the US injectables market.
Applied Clinical Intelligence (ACI) has launched iCommittees to provide a platform to support sponsors’ needs for clinical endpoint adjudication and data monitoring committees (DMC).
Bosch Packaging has identified Asia as a key engine for future growth as its chief announced its international presence had helped the firm to “stand our ground in the global market place” during a tough 2009.
CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up investor support.
M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes a look at M&A processes, pitfalls and keys...
The Institute for OneWorld Health (iOWH) has moved one step closer to supplying a key component of a malaria treatment on an industrial scale as it revealed details of its latest activities to bring the ingredient to regions in short supply.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Almac, BioStorage Technologies and ACM Global.
Quintiles’ Jay Norman tells Outsourcing-pharma that data sharing and patient and payer concerns will drive drug industry competition and clinical development decisions accord to new research.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at GSK, KV Pharmaceutical, ParagonRx, West, Novavax and Unilife.
A new study believes vaccine manufacturers from developing countries may be able to produce a HPV vaccine at a lower cost without infringing on the numerous patents drug makers have taken out on the vaccine technology.
reMYND NV is to offer the A4 amyloid testing service to support preclinical screening of Alzheimer’s treatments after inking a deal with Amorfix Life Sciences.